论文部分内容阅读
目的:探讨利凡诺在瘢痕子宫患者中期引产中的应用效果。方法:将60例住院瘢痕子宫引产患者随机分为研究组和对照组各30例,研究组应用利凡诺(100 mg)羊膜腔内注射引产,对照组应用依沙吖啶(100 mg)羊膜腔内注射引产。围术期均给予严密观察及护理。结果:研究组患者宫缩开始时间(25.35±3.08)h、产程(7.57±2.93)h,均明显短于对照组(30.01±2.11)h、(12.02±1.95)h(P<0.05);引产成功率为100%,明显高于对照组80.00%(P<0.05);胎膜残留率为33.33%,明显低于对照组60.00%(P<0.05);出血量(80.35±3.08)ml,明显少于对照组(125.35±3.08)(P<0.05),两组患者均未出现明显的并发症。结论:利凡诺用于瘢痕子宫患者中期引产的效果理想、安全简便,且科学合理的护理对提高引产术成功率有重要意义。
Objective: To investigate the effect of Rivanol on mid-term induction of labor in patients with uterine scar. Methods: A total of 60 hospitalized patients with cicatricial uterine incuding women were randomly divided into study group and control group, 30 cases in each group were treated with amiodarone (100 mg) Intracavitary induction of labor. Perioperative period were given close observation and care. Results: The onset time of contractions (25.35 ± 3.08 h) and labor (7.57 ± 2.93 h) in study group were significantly shorter than those in control group (30.01 ± 2.11) h and (12.02 ± 1.95) h (P <0.05) The success rate was 100%, which was significantly higher than that of the control group (80.00%, P <0.05). The residual rate of fetal membranes was 33.33%, significantly lower than 60.00% of the control group (P <0.05). The bleeding volume was (80.35 ± 3.08) Less than the control group (125.35 ± 3.08) (P <0.05). No significant complication occurred in both groups. CONCLUSION: Rivanol is an ideal, safe and easy method for mid-term induction of labor in patients with scarring uterus. Scientific and reasonable care is of great importance in improving the success rate of induced abortion.